Predictive factors of low HCO3-levels in peritoneal dialysis patients

Clinical Nephrology

Volumn 63, Issue 4, 2005, Pages 290-296

  Kasimatis, E ^a   Maksich, D ^a   Jassal, V ^a   Bargman, J M ^a   Oreopoulos, D G ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Chronic metabolic acidosis; Chronic peritoneal dialysis; Predictive factors; Venous serum bicarbonates

Indexed keywords

ALKALI; BICARBONATE; CALCIUM CARBONATE; DIALYSIS FLUID; LACTIC ACID; PHOSPHATE BINDING AGENT; POTASSIUM ION; SEVELAMER; UREA;

ADULT; AGED; AGING; ANION GAP; ARTICLE; BICARBONATE BLOOD LEVEL; DOSE RESPONSE; FEMALE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; MULTIVARIATE ANALYSIS; PERITONEAL DIALYSIS; POTASSIUM BLOOD LEVEL; PROTEIN INTAKE; UREA BLOOD LEVEL;

EID: 17444368059     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP63290     Document Type: Article

References (26)

1. Borras M, Marco MP, Fernandez E 2002 Treatment with sevelamer decreases bicarbonate levels in peritoneal dialysis patients. Perit Dial Int 22: 737-738
2. Chertow GM, Burke SK, Dillon MA, Slatopolsky E 1999 Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of hemodialysis patients. Nephrol Dial Transplant 14: 2907-2914
3. Dratwa M, Wilkie M, Ryckelynck JP, ter Wee PM, Rutherford P, Michel C, Hopwood A, Curtis L, Denys N, Divino Filho JC, Faict D 2003 Clinical experience with two physiologic bicarbonate/lactate peritoneal dialysis solutions in automated peritoneal dialysis. Kidney Int Suppl 88: S105-113
4. Dumler F, Galan M 1996 Impact of acidosis on nutritional status in chronic peritoneal dialysis patients. Adv Perit Dial 12: 307-310
5. 2 in serum. Clin Chem 22: 243-245
6. Gallieni M, Cozzolino M, Brancaccio D 2000 Transient decrease of serum bicarbonate levels with sevelamer hydrochloride as the phosphate binder. Kidney Int 57: 1776-1777
7. Graham KA, Hoenich NA, Tarbit M, Ward MK, Goodship TH 1997 Correction of acidosis in hemodialysis patients increases the sensitivity of the parathyroid glands to calcium. J Am Soc Nephrol 8: 627-631
8. Graham KA, Reaich D, Channon SM, Downie S, Gilmour E, Passlick-Deetjen J, Goodship TH 1997 Correction of acidosis in CAPD decreases whole body protein degradation. Kidney Int 51: 1662
9. Halperin ML, Goldstein MB 1999 Fluid, electrolyte, and acid-base physiology. A problem-based approach. Saunders, Philadelphia, pp 5-6
10. Hutchison AJ, Freemont AJ, Boulton HF, Gokal R 1992 Low-calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphatemia whilst minimizing aluminum exposure and hypercalcaemia. Nephrol Dial Transplant 7: 1219-1225
11. Kang SW, Lee SW, Lee IH, Kim BS, Choi KH, Lee HY, Han DS 1997 Impact of metabolic acidosis on serum albumin and other nutritional parameters in long-term CAPD patients. Adv Perit Dial 13: 249-252
12. Kung SC, Morse SA, Bloom E, Raja RM 2001 Acid-base balance and nutrition in peritoneal dialysis. Adv Perit Dial 17: 235-237
13. Lin SH, Lin YF, Cheema-Dhadli S, Davids MR, Halperin ML 2002 Hypercalcaemia and metabolic alkalosis with betel nut chewing: emphasis on its integrative pathophysiology. Nephrol Dial Transplant 17: 708-714
14. Mehrotra R, Kopple JD, Wolfson M 2003 Metabolic acidosis in maintenance dialysis patients: clinical considerations. Kidney Int Suppl 88: S13-25
15. Mujais S 2003 Acid-base profile in patients on PD. Kidney Int Suppl 88: S26-36
16. National Kidney Foundation 2000 DOQI Guidelines. Management of protein and energy intake. Nutrition Guidelines 14 and 16. Available from: http://www.kidney.org/professionals/doqi/guidelines/nut_a14.html and http://www.kidney.org/professionals/doqi/guidelines/nut_a16.html
17. Nolph KD, Prowant B, Serkes KD, Morgan L, Baker B, Charytan C, Gham K, Hamburger R, Husserl F, Kleit S, McGuiness J, Moore H, Warren T 1983 Multicentric evaluation of a new peritoneal dialysis solution with a high lactate and low magnesium concentration. Perit Dial Bull 3: 63-65
18. Ortiz A, Caramelo C 2003 What should plasma bicarbonate levels be in peritoneal dialysis patients? Perit Dial In 23: 606-608
19. Pickering WP, Price SR, Bircher G, Marinovic AC, Mitch WE, Walls J 2002 Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int 61: 1286-1292
20. Rose BD, Post TW 2001 Clinical physiology of acid base and electrolyte disorders. McGraw-Hill, New York, pp 583-590
21. Renal Association 2002 Treatment of Adult Patients with Renal Failure: Recommended Standards and Audit Measures. 3rd ed. Royal College of Physicians and the Renal Association. London, pp 58-59
22. Sadek T, Mazouz H, Bahloul H, Oprisiu R, El Esper N, El Esper I, Boitte F, Brazier M, Moriniere P, Fournier A 2003 Sevelamer hydrochloride with or without alpha-calcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open-label, randomized study. Nephrol Dial Transplant 18: 582-588
23. Tannen RL 1987 Effect of potassium on renal acidification and acid-base homeostasis. Semin Nephrol 7: 263-273.
24. Tranaeus A 2000 A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution - clinical benefits. The Bicarbonate/Lactate Study Group. Perit Dial Int 20: 516-523
25. Uribarri J, Buquing J, Oh MS 1995 Acid-base balance in chronic peritoneal dialysis patients. Kidney Int 47: 269-273
26. Walls J 1995 Metabolic acidosis and uremia. Perit Dial Int 15: S36-38